This section contains references to information on clinical trials related to carcinoid cancer and neuroendocrine tumors. This section may not represent an inclusive list of all clinical trials that are in process or being planned worldwide.
- Clinical Trials.gov
- Specifically for carcinoid
- Specifically for neuroendocrine tumors
- Specifically for lung carcinoid
- Specifically for multiple endocrine neoplasia (MEN)
- Specifically for pancreatic neuroendocrine tumors
- Specifically for paraganglioma
- Specifically for pheochromocytoma
The U.S. National Institutes of Health, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members and members of the public current information about clinical research studies.
For additional clinical trials contact the NCI’s Cancer Information service at 800-422-6237
STARTRK-2: A Basket Trial for Neuroendocrine Tumor Patients with Specific Gene Rearrangements
Precision medicine, molecular testing, basket studies, STARTRK-2 – it may sound like technology of the future but it is here today and it might be the answer to slowing or stopping tumor growth for neuroendocrine tumor (NET) patients who have specific gene rearrangements.
Read more about the trial here: https://www.carcinoid.org/2017/04/07/startrk-2-basket-trial-neuroendocrine-tumor-patients-specific-gene-rearrangements/
Please also visit North American NeuroEndocrine Tumor Society (NANETS) for current clinical trials information: https://www.nanets.net/content/current-clinical-trials
This study is currently recruiting participants. Verified by National Institutes of Health Clinical Center (CC), September 2016
Article published in Gastroenterology in 2015:
Information from the NIH:
Do You Understand Clinical Trials? Excellent, short video from the European Patients’ Academy (EUPATI). Read more and watch the video